Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Aug;64(2):369–372. doi: 10.1038/bjc.1991.309

Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.

A van der Gaast 1, W L van Putten 1, R Oosterom 1, M Cozijnsen 1, R Hoekstra 1, T A Splinter 1
PMCID: PMC1977505  PMID: 1654076

Abstract

In a group of seventy patients with small cell lung cancer the prognostic value of serum tumour markers was determined. Thymidine kinase (TK), tissue polypeptide antigen (TPA) and lactate dehydrogenase (LDH) but not neuron specific enolase (NSE) correlated significantly with survival. Since all markers were strongly interrelated with each other and with the extent of disease, the combined determination of TK, TPA and LDH or the combination of disease extent and a marker yielded no more prognostic information than a single measurement of one of these variables.

Full text

PDF
369

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akoun G. M., Scarna H. M., Milleron B. J., Bénichou M. P., Herman D. P. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. Chest. 1985 Jan;87(1):39–43. doi: 10.1378/chest.87.1.39. [DOI] [PubMed] [Google Scholar]
  2. Buccheri G. F., Ferrigno D., Sartoris A. M., Violante B., Vola F., Curcio A. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9. Cancer. 1987 Jul 1;60(1):42–50. doi: 10.1002/1097-0142(19870701)60:1<42::aid-cncr2820600109>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  3. Carney D. N., Marangos P. J., Ihde D. C., Bunn P. A., Jr, Cohen M. H., Minna J. D., Gazdar A. F. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet. 1982 Mar 13;1(8272):583–585. doi: 10.1016/s0140-6736(82)91748-2. [DOI] [PubMed] [Google Scholar]
  4. Cerny T., Blair V., Anderson H., Bramwell V., Thatcher N. Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer. 1987 Feb 15;39(2):146–149. doi: 10.1002/ijc.2910390204. [DOI] [PubMed] [Google Scholar]
  5. Cooper E. H., Splinter T. A., Brown D. A., Muers M. F., Peake M. D., Pearson S. L. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer. 1985 Sep;52(3):333–338. doi: 10.1038/bjc.1985.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Greengard O., Head J. F., Goldberg S. L., Kirschner P. A. Biochemical measure of the volume doubling time of human pulmonary neoplasms. Cancer. 1985 Apr 1;55(7):1530–1535. doi: 10.1002/1097-0142(19850401)55:7<1530::aid-cncr2820550720>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  7. Gronowitz J. S., Källander F. R., Diderholm H., Hagberg H., Pettersson U. Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans. Int J Cancer. 1984 Jan 15;33(1):5–12. doi: 10.1002/ijc.2910330103. [DOI] [PubMed] [Google Scholar]
  8. Gronowitz J. S., Steinholtz L., Källander C. F., Hagberg H., Bergh J. Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers. Cancer. 1986 Jul 1;58(1):111–118. doi: 10.1002/1097-0142(19860701)58:1<111::aid-cncr2820580120>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  9. Jørgensen L. G., Osterlind K., Hansen H. H., Cooper E. H. The prognostic influence of serum neuron specific enolase in small cell lung cancer. Br J Cancer. 1988 Dec;58(6):805–807. doi: 10.1038/bjc.1988.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Maurer L. H., Pajak T. F. Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study. Cancer Treat Rep. 1981 Sep-Oct;65(9-10):767–774. [PubMed] [Google Scholar]
  11. Reeve J. G., Stewart J., Watson J. V., Wulfrank D., Twentyman P. R., Bleehen N. M. Neuron specific enolase expression in carcinoma of the lung. Br J Cancer. 1986 Apr;53(4):519–528. doi: 10.1038/bjc.1986.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shackney S. E., McCormack G. W., Cuchural G. J., Jr Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. Ann Intern Med. 1978 Jul;89(1):107–121. doi: 10.7326/0003-4819-89-1-107. [DOI] [PubMed] [Google Scholar]
  13. Souhami R. L., Bradbury I., Geddes D. M., Spiro S. G., Harper P. G., Tobias J. S. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res. 1985 Jun;45(6):2878–2882. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES